Business Context and Reporting Period
Company: The Procter & Gamble Company (P&G)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended December 31, 2024 (Fiscal Year 2025 Q2)
Business Overview: P&G is a global leader in fast-moving consumer goods, operating across five reportable segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The company sells products in approximately 180 countries.
Key Financial Metrics
| Metric (in millions, except per share) | Three Months Ended Dec 31, 2024 | Six Months Ended Dec 31, 2024 |
|---|---|---|
| Net Sales | $21,882 | $43,619 |
| Operating Income | $5,741 | $11,538 |
| Net Earnings Attributable to P&G | $4,630 | $8,589 |
| Diluted EPS | $1.88 | $3.49 |
| Operating Cash Flow (6 months) | $9,127 | |
| Adjusted Free Cash Flow (6 months) | $7,771 | |
| Cash and Cash Equivalents (Dec 31, 2024) | $10,230 | |
| Total Debt (Current + Long-Term) | $34,687 | |
| Gross Margin (6 months) | 52.2% |
Material Changes vs. Prior Comparable Period
- Revenue Growth: Net sales increased 2% for the quarter and 1% for the six-month period compared to the prior year. Organic sales (excluding FX and acquisitions/divestitures) grew 3% for the quarter and 2% for the six months.
- Profitability Surge: Net earnings increased 33% for the quarter and 7% for the six months. This significant year-over-year improvement is primarily driven by a $1.3 billion non-cash impairment charge on the Gillette intangible asset recorded in the prior year (2023), which is absent in the current period.
- Restructuring Charges: The current period included incremental restructuring charges of approximately $0.8 billion after tax, largely due to the liquidation of operations in Argentina and Nigeria. This partially offset the earnings benefit from the absence of the prior year's impairment.
- Segment Performance:
- Beauty: Sales were flat for the quarter but down 3% for the six months, driven by declines in Skin Care (SK-II) and Hair Care in Greater China.
- Fabric & Home Care: Sales increased 2% (quarter) and 1% (six months), supported by volume growth in North America and Europe.
- Health Care: Sales increased 2% in both periods, driven by pricing and mix.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted strong organic volume growth and productivity savings that offset higher commodity costs and unfavorable foreign exchange impacts. The company reaffirmed its commitment to share repurchases, targeting $6 to $7 billion in fiscal year 2025.
Risks and Contingencies:
- Foreign Exchange: Significant exposure to currency fluctuations, particularly the weakening of certain currencies against the U.S. dollar, which negatively impacted sales and earnings.
- Restructuring: Ongoing liquidation of operations in Argentina resulted in substantial non-cash charges related to accumulated foreign currency translation losses.
- Intangible Assets: The Gillette indefinite-lived intangible asset remains sensitive to changes in discount rates, growth rates, and currency devaluation. While fair value currently exceeds carrying value by over 10%, adverse macroeconomic changes could trigger further impairment.
- Commodities: Volatility in oil-derived materials (resins) and paper-based materials (pulp) continues to pressure costs.
Investor Verification Checklist
- Core EPS vs. GAAP EPS: Verify the reconciliation between reported Diluted EPS ($3.49) and Core EPS ($3.81) to understand the impact of the Argentina restructuring charges and the prior year's Gillette impairment.
- Argentina Restructuring: Confirm the nature of the $0.8 billion after-tax charge, specifically the portion attributed to non-cash foreign currency translation losses versus cash restructuring costs.
- Beauty Segment Trends: Investigate the specific drivers behind the decline in the Skin Care category (SK-II) and Hair Care in Greater China, as these represent significant headwinds.
- Debt Maturity Profile: Review the schedule of debt maturities, noting the significant current portion of debt ($9.4 billion) and the company's reliance on operating cash flow and refinancing capabilities.
- Share Repurchase Execution: Monitor the pace of the $6-$7 billion share repurchase program authorized for fiscal 2025 against actual cash flow generation.